ARPEGGIO BIO
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.
ARPEGGIO BIO
Industry:
Biotechnology Health Care Machine Learning Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.arpeggiobio.com
Total Employee:
11+
Status:
Active
Total Funding:
20.35 M USD
Technology used in webpage:
U.S. Server Location Pound Sterling Japanese Yen
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Enveda Biosciences
Enveda Biosciences is a biotechnology company building new medicines from plants.
Foresight Diagnostics
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Jio Health
Jio Health tracks vitals, manages medications, and connects with providers and caregivers in meaningful ways.
SonarMD
SonarMD provides care management for complex chronic conditions that use high-cost drugs.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Turning Point Therapeutics
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
Current Advisors List
Advisor
2022-09-01
Advisor
2022-09-01
Current Employees Featured
Joey Azofeifa Founder and CEO @ Arpeggio Bio
Founder and CEO
2017-08-01
Laura Norris Co-Founder and COO @ Arpeggio Bio
Co-Founder and COO
2018-03-01
Joey Azofeifa Founder and CEO @ Arpeggio Bio
Founder and CEO
2019-02-01
Tim Read Co-Founder and CTO @ Arpeggio Bio
Co-Founder and CTO
2021-09-01
Founder
Investors List
TechU Ventures
TechU Ventures investment in Series A - Arpeggio Bio
ATEM Capital Fund LP
ATEM Capital Fund LP investment in Series A - Arpeggio Bio
Milad Alucozai
Milad Alucozai investment in Series A - Arpeggio Bio
Builders VC
Builders VC investment in Series A - Arpeggio Bio
Fifty Years
Fifty Years investment in Series A - Arpeggio Bio
Formic Ventures
Formic Ventures investment in Series A - Arpeggio Bio
FundersClub
FundersClub investment in Series A - Arpeggio Bio
Matt De Silva
Matt De Silva investment in Series A - Arpeggio Bio
Alice Zhang
Alice Zhang investment in Series A - Arpeggio Bio
Khosla Ventures
Khosla Ventures investment in Series A - Arpeggio Bio
Official Site Inspections
http://www.arpeggiobio.com Semrush global rank: 9.08 M Semrush visits lastest month: 445
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Arpeggio Bio"
Arpeggio Bio
We engineer medicine based not on a single target, but the biological network as a whole.See details»
About Us - Arpeggio Bio
Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer.See details»
Arpeggio Bio - Crunchbase Company Profile & Funding
Contact Email info@arpeggiobio.com Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to …See details»
Arpeggio Bio: Arpeggio Bio develops drugs targeting transcription ...
Arpeggio Bio develops drugs targeting transcription factors using AI…. Founded in 2018 by Joey Azofeifa, Arpeggio Bio has 20 employees based in Boulder, CO, USA.See details»
Arpeggio Biosciences Company Profile -Sales, Contacts, …
Www.arpeggiobio.com: There are 4 Companies located at 4888 PEARL EAST CIR, Boulder, CO 80301 Map ... Research, and Management Services sector. This organization has been …See details»
Arpeggio Biosciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Arpeggio Biosciences, Inc. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
Arpeggio Biosciences - Golden
Arpeggio Biosciences is a biotechnology company headquartered in Boulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is …See details»
Arpeggio Biosciences - Craft
Arpeggio Biosciences has 5 employees at their 1 location and $3.35 m in total funding,. See insights on Arpeggio Biosciences including office locations, competitors, revenue, financials, …See details»
Arpeggio Bio - BIO International Convention | BIO
Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Arpeggio Biosciences CEO and Key Executive Team | Craft.co
Arpeggio Biosciences's Co-Founder, CEO is Joey Azofeifa. Other executives include Laura Norris, COO & Co-Founder; Tim Read, CTO & Co-Founder. See the full leadership team at Craft.See details»
Arpeggio Bio
Arpeggio is developing the world's fastest platform for transcriptomic sequencing to learn how chemistry maps to network biology.See details»
Arpeggio 2025 Company Profile: Valuation, Funding & Investors
Arpeggio General Information Description. Developer of a drug assessment technology designed to study mechanistic understanding of how drugs work. The company's platform combines its …See details»
Arpeggio Bio Raises $3.2 Million in Seed Funding and ... - Business …
Jan 15, 2020 BOULDER, Colo.--(BUSINESS WIRE)--Arpeggio Bio, a preclinical company whose technology provides a mechanistic understanding of how drugs work, today announced that it …See details»
Arpeggio Bio Raises $3.2 Million in Seed Funding and CEO Named …
Jan 15, 2020 The organization’s focus is to support the business development of early-stage… Learn More As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability …See details»
Careers - Arpeggio Bio
Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer.See details»
Arpeggio Bio Company Profile: Funding, Investors & Partnerships
Arpeggio builds technology to watch and learn how drugs work using the epigenome. Scientists have been measuring gene activity in our cells for over twenty years now, but it’s remained a …See details»
Arpeggio Bio Raises $3.2 Million in Seed Funding and CEO
Jan 15, 2020 BOULDER, Colo.--(BUSINESS WIRE)-- Arpeggio Bio, a preclinical company whose technology provides a mechanistic understanding of how drugs work, today announced …See details»
Technology - Arpeggio Bio
Every cell in our body has the same genome, but a hair follicle looks a lot different than a neuron. This is due to a cell’s transcriptome: the set of more than 20,000 mRNAs uniquely oriented to …See details»
Arpeggio Blog
Arpeggio Blog Musings about science, startups, and mathematics. Dynamic Transcriptomics Watching Transcriptomics. Posted by Joey Azofeifa on June 1st, 2020See details»
News - Arpeggio Bio
This Nature paper from Kim et al. illuminates a really exciting mechanism underpinning chronic kidney disease and ferroptosis. In patients with type 2 diabetes, nephrons had significantly …See details»